NMRA Dividend History & Analysis | N/A Yield
NMRA has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Pharmaceuticals
| Symbol | Market Cap USD | Dividend Yield TTM | Yield on Cost 5y |
|---|---|---|---|
| NBY | 668 M | 17.5% | 0.14% |
| SIGA | 457 M | 9.63% | 11.1% |
| PFE | 142,370 M | 8.64% | 7.45% |
| PRGO | 1,839 M | 8.48% | 3.11% |
| SAN | 117,496 M | 4.77% | 6.07% |
| Symbol | Market Cap USD | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| RPRX | 22,341 M | 29.4% | 100% |
| ZTS | 54,857 M | 21.2% | 100% |
| LLY | 960,500 M | 15.1% | 96.1% |
| SIGA | 457 M | 15.5% | 98.8% |
| MRK | 251,502 M | 5.91% | 93.7% |
Similar Stocks with Attractive Dividends - Compare NMRA Dividends with its Peer-Group
9.63% Yield
4.77% Yield
3.12% Yield
2.50% Yield
4.57% Yield
2.87% Yield
NMRA Dividend History: as of December 2025
No dividends paid yet.NMRA Dividend FAQ
Neumora Therapeutics (NASDAQ: NMRA) is a clinical-stage biopharma focused on oral small-molecule therapies for central-nervous-system (CNS) disorders, including major depressive disorder (MDD), dementia-related agitation, schizophrenia, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and other neurodegenerative conditions. Its lead asset, navacaprant (NMRA-140), is a once-daily kappa-opioid receptor antagonist currently in a pivotal Phase 3 trial for MDD, while NMRA-511 is in Phase 1 for agitation in Alzheimer’s disease.
What is the Dividend Yield of NMRA?
As of December 2025, NMRA`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 1.81.Does NMRA pay a dividend?
As of December 2025 NMRA does not pay a dividend.How often does NMRA pay dividends?
Over the last 12 months, NMRA has issued dividend payments.NMRA dividend forecast
Based on historical data, the forecasted dividends per share for NMRA for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).This suggests the dividend will remain relatively stable.
Will NMRA pay dividends in 2025?
The next Ex-Dividend date for Neumora Therapeutics (NMRA) is currently unknown.What is the next Ex-Dividend Date for NMRA?
The next Ex-Dividend date for Neumora Therapeutics (NMRA) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of NMRA?
NMRA's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of NMRA?
NMRA's 5-Year Yield on Cost is -%. If you bought NMRA's shares at 17.00 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of NMRA?
NMRA Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does NMRA have a good Dividend Yield?
NMRA`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of NMRA?
The Dividend Payout Ratio of NMRA is unknown.What is the Dividend Rating of NMRA?
NMRA`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-12-12 04:45